Skip to main content
. 2021 Jun 30;15(6):e0009513. doi: 10.1371/journal.pntd.0009513

Table 4. Demographic and clinical characteristics of patients with secondary vs. primary dengue infection among the dengue-confirmed cases from the health facility-based fever surveillance established in Bang Phae district, Ratchaburi province, Thailand in 2011–2016.

Characteristics
(n; %)
Secondary dengue infection
(n=95)
Primary dengue infection
(n=35)
Dengue-confirmed
(n=130)
p-value Univariable analysis
Secondary vs. primary dengue
OR 95% CI p-value
Age (years) 0.216 0.252
1-9 20 (21.1) 13 (37.1) 33 (25.4) Ref*
10-14 31 (32.6) 9 (25.7) 40 (30.77) 2.24 0.81-6.20
15-19 20 (21.1) 9 (25.7) 29 (22.31) 1.44 0.51-4.14
20-34 14 (14.7) 3 (8.6) 17 (13.1) 3.03 0.73-12.67
35-55 10 (10.5) 1 (2.9) 11 (8.5) 6.50 0.74-56.99
Female 47 (49.5) 19 (54.3) 66 (50.77) 0.626 0.83 0.38-1.79 0.627
Hospitalization
No 51 (53.7) 28 (80.0) 79 (60.77) 0.001 Ref*
Yes 44 (46.3) 7 (20.0) 51 (39.23) 3.45 1.37-8.67 0.008
Days of stay (mean; SD) 4.17 (1.46) 3.71 (1.38) 4.10 (1.45) <.001
Duration of fever, prior to visit (days)
Mean (SD) 3.21 (1.15) 3.74 (1.40) 3.35 (1.24) <.001 0.266
3 (ref. 1-2 days) 0.92 0.29-2.89
4-7 0.50 0.20-1.30
Duration of fever, entire illness (days)
Mean (SD) 6.44 (2.18) 6.59 (2.05) 6.48 (2.14) <.001
Temperature at presentation (°C) 0.044 0.105
< 38.3 52 (54.7) 26 (74.3) 78 (60.0) Ref*
≥ 38.3 43 (45.3) 9 (25.7) 52 (40.0) 1.91 0.87-4.19
High body temp at enrollment (ref. lower temp) 2.39 1.01-5.64 0.047
JE vaccination 82 (86.3) 32 (91.4) 114 (87.69) 0.431 0.59 0.16-2.21 0.435
Positive on the NS1 of RDT 63 (66.3) 21 (60.0) 84 (64.6) 0.504 1.31 0.59-2.92 0.505
Clinical diagnosis
Suspected dengue 66 (69.5) 19 (54.3) 85 (65.4) 0.107 1.92 0.87-4.25 0.109
Suspected DF/DHF 58/8 19/0 77/8 - - -
Other than dengue 29 (30.5) 16 (45.7) 45 (34.6) Ref*
Signs and symptoms (ref. absence)
Rash 11 (11.6) 7 (20.0) 18 (13.85) 0.218 0.52 0.19-1.48 0.223
Fatigue/weakness 34 (35.8) 6 (17.1) 40 (30.77) 0.041 2.69 1.02-7.14 0.046
Alterations of consciousness 22 (23.2) 5 (14.3) 27 (20.77) 0.269 1.81 0.63-5.22 0.273
Headache 87 (91.6) 30 (85.7) 117 (90.0) 0.323 1.81 0.55-5.97 0.328
Retro-orbital pain 13 (13.7) 3 (8.6) 16 (12.31) 0.431 1.69 0.45-6.33 0.435
Rhinorrhea 17 (17.9) 8 (22.9) 25 (19.23) 0.524 0.74 0.29-1.90 0.525
Sore Throat 35 (36.8) 12 (34.3) 47 (36.15) 0.788 1.12 0.50-2.52 0.788
Cough 36 (37.9) 13 (37.1) 49 (37.69) 0.938 1.03 0.46-2.30 0.938
Nausea & vomiting 45 (47.4) 8 (22.9) 53 (40.77) 0.012 3.04 1.25-7.37 0.014
Abdominal pain 9 (9.5) 6 (17.1) 15 (11.54) 0.113 0.51 0.17-1.54 0.231
Loss of appetite 42 (44.2) 8 (22.9) 50 (38.46) 0.026 2.68 1.10-6.49 0.030
Muscle pain 33 (34.7) 4 (11.4) 37 (28.46) 0.009 4.12 1.34-12.68 0.014
Joint pain 6 (6.3) 0 6 (4.62) 0.146 -
Hematemesis 11 (11.6) 3 (8.6) 14 (10.77) 0.624 1.40 0.37-5.33 0.625

*reference category